VERABREICHUNG EINES ANTITUMORMITTELS

European patent · EP2827858 · In force

Register entry

Publication number
EP2827858
Application number
EP13711004
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 15, 2013
Published
Jan 28, 2015
Granted
Jul 20, 2016
Protection ends at the latest
Mar 14, 2033
Next annual fee due
Mar 31, 2027
IPC classes
A61K 9/14 (2006.01)
A61K 31/40 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201261612429 P 19.03.2012
PCT application
PCT/EP2013/055324 15.03.2013
PCT publication
WO2013/139687 26.09.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Jul 20, 2016

    Granted

    Published in Swissreg on 20.07.2016

Parties

Holder

F. Hoffmann-La Roche AG

F.Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

GLENN, Kelli

Roseland New Jersey 07068, US

HIGGINS, Brian

Fresh Meadows New York 11365, US

NICHOLS, Gwen

New York New York 10128, US

PACKMAN, Kathryn E.

Bloomfield New Jersey 07003, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.